Clinical Trials Logo

Clinical Trial Summary

Implanted port devices (IPD) play an essential role in the safe administration of cancer treatments by providing a device to safely administer caustic chemotherapy agents. The current recommended frequency of flushing the IPD per manufacturers guidelines is every 4-6 weeks. The purpose of this study is to find out if extending IPD flushes to every 12 weeks is safe and if it is just as effective as every 4 week flushing.


Clinical Trial Description

After being informed about the study and potential risks, all participants giving written informed consent will complete port specific histories, assessments and questionnaires within 14 days prior to registration. Eligible, consented participants will be registered to the study and randomized to receive either IPD standard maintenance flushes and port assessments every 4 weeks or every 12 weeks for an initial 12 week interval. If study participants agree to the continuation portion of the study, they will continue to receive either IPD standard maintenance flushes and port assessments every 4 weeks or every 12 weeks for up to an additional three 12 week cycles. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05454189
Study type Interventional
Source Essentia Health
Contact Bret Friday, MD, PhD
Phone 218-786-3625
Email bret.friday@essentiahealth.org
Status Recruiting
Phase N/A
Start date October 11, 2022
Completion date October 1, 2024